Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Oct 23:9:622.
doi: 10.3389/fendo.2018.00622. eCollection 2018.

Metformin and Colorectal Cancer

Takuma Higurashi  1 , Atsushi Nakajima  1
Affiliations
Review

Metformin and Colorectal Cancer

Takuma Higurashi et al. Front Endocrinol (Lausanne). .

Abstract

Colorectal Cancer (CRC) is one of the most frequently encountered neoplasms in humans. The incidence of CRC has been increasing and new strategies for prevention, including chemoprevention, are required to lower its incidence and associated mortality. Metformin is a biguanide compound commonly used for the treatment of diabetes mellitus. Many recent basic research, epidemiological and clinical trial studies have indicated that metformin has benefits not only in diabetes treatment, but also in lowering the risk of developing cancer (including CRC). These studies indicate that metformin may be a candidate chemoprevention agent for CRC. This review article shall discuss the present evidence of metformin treatment and CRC, as well as outline our challenge in the investigation of metformin use in chemoprevention therapy for colorectal tumors.

Keywords: basic research; chemoprevention; clinical trials; colorectal cancer; epidemiology; metfromin; review.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Endoscopic features of Aberrant Crypt Foci (ACF).
Figure 2
Figure 2
Trial profile. This figure is reproduced from (53) with permission.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. (2018) 68:7–30. 10.3322/caac.21442 - DOI - PubMed
    1. Penny LK, Wallace HM. The challenges for cancer chemoprevention. Chem Soc Rev. (2015) 44:8836–47. 10.1039/C5CS00705D - DOI - PubMed
    1. Winawer SJ, Zauber AG, Ho MN, O'Brien MJ, Gottlieb LS, Sternberg SS, et al. . Prevention of colorectal cancer by colonoscopic polypectomy. the national polyp study workgroup. N Engl J Med. (1993) 329:1977–81. 10.1056/NEJM199312303292701 - DOI - PubMed
    1. Imperiale TF, Glowinski EA, Lin-Cooper C, Larkin GN, Rogge JD, Ransohoff DF. Five-year risk of colorectal neoplasia after negative screening colonoscopy. N Engl J Med. (2008) 359:1218–24. 10.1056/NEJMoa0803597 - DOI - PubMed
    1. Research WCRFAIfC. Colorectal Cancer 2011 Report. (2011).

LinkOut - more resources